Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$26.3M
+6.1% from 2023
Prescriptions
2,290
$11,484.68 per claim
Patients
463
283 prescribers
Total spending, 2024
$26.3M
$56,803.26 per patient
Medicare prescription drug plans paid $26.3M for Imfinzi in 2024, for 2,290 prescriptions and refills to 463 patients (up 6.1% from 2023). The average cost per claim was $11,484.68.
New York had the highest Medicare cost for Imfinzi in 2024: $6.6M for 581 claims, followed by Florida ($3.4M).
Avi S Retter, hematology-oncology in Bronx, NY, had the highest Medicare cost for Imfinzi in 2024: 52 claims costing $561K.
Imfinzi is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Avi S Retter Bronx, NY | Hematology-Oncology | 52 | Under 11 | $561K |
| Norland Ng New York, NY | Hematology-Oncology | 33 | Under 11 | $454K |
| Samuel D Bailey Hazard, KY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 153 | 1,193 | 227 | $12.4M |
| 2023 | 246 | 2,138 | 401 | $24.8M |
| 2024 | 283 | 2,290 | 463 | $26.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 45 |
| Under 11 |
| $426K |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 35 | Under 11 | $380K |
| Asit J Choksi The Woodlands, TX | Hematology-Oncology | 31 | Under 11 | $379K |
| Daniel Castro Orange City, FL | Hematology-Oncology | 35 | Under 11 | $369K |
| Swetha S Yadav Kearney, NE | Hematology-Oncology | 30 | Under 11 | $366K |
| Gardith Joseph Brooklyn, NY | Hematology-Oncology | 30 | Under 11 | $362K |
| Andrew R Beardsley Asheville, NC | Internal Medicine | 41 | Under 11 | $350K |
| Bilawal Ahmed Memphis, TN | Hematology-Oncology | 28 | Under 11 | $341K |
| Tarek I Hassanein Coronado, CA | Gastroenterology | 26 | 14 | $326K |
| Manuel F Gonzalez Sumter, SC | Hematology-Oncology | 26 | Under 11 | $313K |
| Trevor Layne West Orange, NJ | Hematology-Oncology | 24 | Under 11 | $309K |
| Arjun Iyengar New York, NY | Hematology-Oncology | 25 | Under 11 | $305K |
| John J Graham Canfield, OH | Hematology-Oncology | 39 | Under 11 | $303K |
| Kamlesh P Sajnani Harlan, KY | Medical Oncology | 17 | Under 11 | $266K |
| Fauzia Paracha Newburgh, NY | Hematology-Oncology | 21 | Under 11 | $256K |
| Benjamin P Negin Vineland, NJ | Hematology-Oncology | 22 | Under 11 | $255K |
| Colt Williams Reno, NV | Internal Medicine | 19 | Under 11 | $245K |
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 20 | Under 11 | $243K |
| Vinicio Hernandez Orlando, FL | Medical Oncology | 19 | Under 11 | $231K |
| Byung M Kim Elmhurst, NY | Medical Oncology | 18 | Under 11 | $224K |
| Saleha S Sajid Kingwood, TX | Hematology | 17 | Under 11 | $224K |
| Rahul R Naik Los Angeles, CA | Hematology-Oncology | 19 | Under 11 | $221K |
| Gregory L Ortega Orange City, FL | Hematology-Oncology | 19 | Under 11 | $217K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 2,290 | $26.3M |